Vonoprazan Fumarate is the fumarate salt form of vonoprazan, a pyrrole derivative and reversible potassium-competitive acid blocker (P-CAB) with potential antacid activity. It acts by binding to the gastric hydrogen-potassium ATPase proton pump to inhibit gastric acid secretion.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 881681-01-2
Vonoprazan Fumarate
potassium-competitive acid blocker
Vonoprazan Fumarate
potassium-competitive acid blocker
Vonoprazan
active pharmaceutical ingredient
5-(2-Fluorophenyl)-1-(3-pyridinylsulfonyl)-1H-pyrrole-3-methanol
Pharmaceutical intermediate
(+)-Catechin Hydrate
pharmaceutical reference standard
Netobimin Sodium Salt
anthelmintic active pharmaceutical ingredient
1,4-Bis[3,4-dihydro-2(1H)-quinolinon-7-oxy]butane
pharmaceutical impurity
Clodronate disodium tetrahydrate
bisphosphonate bone resorption inhibitor
(E)-but-2-enedioic acid;1-[5-(2-fluorophenyl)-1-pyridin-3-ylsulfonylpyrrol-3-yl]-N-methylmethanamine
ROGSHYHKHPCCJW-WLHGVMLRSA-N
CNCC1=CN(C(=C1)C2=CC=CC=C2F)S(=O)(=O)C3=CN=CC=C3.C(=C/C(=O)O)\C(=O)O